Indication Taxonomy Review
19 therapeutic areas, 158 indications
Coverage: 79,865 / 262,826 condition mentions matched (30.4%)
Oncology
40 indications 34,427 trials
Solid Tumor (Advanced) (4,754 trials)
Breast Cancer (3,119 trials)
NSCLC (2,444 trials)
Colorectal Cancer (1,890 trials)
Prostate Cancer (1,622 trials)
Non-Hodgkin Lymphoma (1,613 trials)
Multiple Myeloma (1,455 trials)
Melanoma (1,163 trials)
AML (1,148 trials)
Head and Neck Cancer (1,079 trials)
Pancreatic Cancer (1,028 trials)
Hepatocellular Carcinoma (1,004 trials)
Ovarian Cancer (1,000 trials)
MDS (862 trials)
Gastric Cancer (827 trials)
Glioblastoma (757 trials)
Lung Cancer (General) (742 trials)
Bladder Cancer (631 trials)
Sarcoma (631 trials)
Esophageal Cancer (630 trials)
Hematologic Malignancies (568 trials)
Renal Cell Carcinoma (527 trials)
CLL (501 trials)
Cholangiocarcinoma (443 trials)
ALL (414 trials)
Cervical Cancer (397 trials)
Endometrial Cancer (380 trials)
Triple Negative Breast Cancer (367 trials)
Brain Tumor (346 trials)
SCLC (323 trials)
Hodgkin Lymphoma (278 trials)
Myelofibrosis (246 trials)
Neuroendocrine Tumors (241 trials)
CML (196 trials)
HER2+ Breast Cancer (171 trials)
Mesothelioma (156 trials)
Squamous Cell Carcinoma (153 trials)
Thyroid Cancer (144 trials)
HER2- Breast Cancer (104 trials)
Merkel Cell Carcinoma (73 trials)
CNS
18 indications 8,391 trials
Major Depression (1,393 trials)
Alzheimer's Disease (1,379 trials)
Schizophrenia (850 trials)
Parkinson's Disease (744 trials)
Multiple Sclerosis (548 trials)
Alcohol Use Disorder (448 trials)
Opioid Use Disorder (416 trials)
Migraine (365 trials)
Anxiety (323 trials)
Autism Spectrum Disorder (321 trials)
Epilepsy (311 trials)
ALS (293 trials)
Bipolar Disorder (271 trials)
ADHD (241 trials)
PTSD (229 trials)
Huntington's Disease (102 trials)
Neuropathy (93 trials)
OCD (64 trials)
Metabolic
7 indications 7,461 trials
Type 2 Diabetes (2,633 trials)
Obesity (1,606 trials)
Diabetes (General) (975 trials)
Type 1 Diabetes (795 trials)
Dyslipidemia (538 trials)
Diabetic Complications (490 trials)
NASH/NAFLD (424 trials)
Infectious Disease
13 indications 6,836 trials
COVID-19 (1,955 trials)
HIV (1,331 trials)
Influenza (801 trials)
Hepatitis C (692 trials)
Hepatitis B (484 trials)
Sepsis (482 trials)
Malaria (369 trials)
Tuberculosis (287 trials)
H. pylori (156 trials)
Bacterial Infections (115 trials)
Fungal Infections (85 trials)
RSV (73 trials)
C. difficile (6 trials)
Cardiovascular
9 indications 5,094 trials
Hypertension (1,415 trials)
Stroke (907 trials)
Coronary Artery Disease (905 trials)
Heart Failure (847 trials)
Atrial Fibrillation (358 trials)
Myocardial Infarction (298 trials)
Thrombosis (273 trials)
Arrhythmia (56 trials)
Hypertrophic Cardiomyopathy (35 trials)
Immunology
15 indications 4,683 trials
Rheumatoid Arthritis (969 trials)
Psoriasis (852 trials)
Atopic Dermatitis (737 trials)
Crohn's Disease (480 trials)
Ulcerative Colitis (414 trials)
Lupus (327 trials)
Psoriatic Arthritis (129 trials)
Myasthenia Gravis (129 trials)
Lupus Nephritis (116 trials)
Hidradenitis Suppurativa (110 trials)
IgA Nephropathy (102 trials)
Chronic Spontaneous Urticaria (95 trials)
Ankylosing Spondylitis (88 trials)
IBD (81 trials)
NMOSD (54 trials)
Respiratory
7 indications 3,271 trials
Asthma (1,225 trials)
COPD (920 trials)
Cystic Fibrosis (431 trials)
Idiopathic Pulmonary Fibrosis (265 trials)
Allergic Rhinitis (195 trials)
Pneumonia (170 trials)
Chronic Rhinosinusitis with Nasal Polyps (65 trials)
Pain
4 indications 2,686 trials
Acute Pain (1,290 trials)
Postoperative Pain (979 trials)
Chronic Pain (275 trials)
Neuropathic Pain (142 trials)
Rare Disease
9 indications 1,081 trials
Sickle Cell Disease (359 trials)
Hemophilia (239 trials)
Immune Thrombocytopenia (191 trials)
Duchenne Muscular Dystrophy (142 trials)
Fabry Disease (61 trials)
Spinal Muscular Atrophy (44 trials)
Gaucher Disease (26 trials)
Mastocytosis (15 trials)
CDKL5 Deficiency Disorder (4 trials)
Women's Health
5 indications 1,034 trials
Infertility (364 trials)
Contraception (191 trials)
PCOS (176 trials)
Menopause (161 trials)
Endometriosis (142 trials)
Musculoskeletal
4 indications 821 trials
Osteoarthritis (291 trials)
Osteoporosis (275 trials)
Gout (203 trials)
Muscle Spasm (52 trials)
Renal
2 indications 777 trials
Chronic Kidney Disease (589 trials)
Acute Kidney Injury (188 trials)
Ophthalmology
3 indications 772 trials
Dry Eye (342 trials)
Glaucoma (266 trials)
Age-Related Macular Degeneration (164 trials)
Dermatology
5 indications 741 trials
Acne (356 trials)
Alopecia (195 trials)
Vitiligo (75 trials)
Rosacea (72 trials)
Skin Infections (43 trials)
Gastrointestinal
5 indications 635 trials
Nausea/Vomiting (167 trials)
Constipation (162 trials)
GERD (126 trials)
Diarrhea (114 trials)
Peptic Ulcer (66 trials)
Urology
3 indications 489 trials
Overactive Bladder (222 trials)
Erectile Dysfunction (165 trials)
Benign Prostatic Hyperplasia (102 trials)
Hepatology
2 indications 281 trials
Cirrhosis (232 trials)
Liver Failure (49 trials)
Sleep
2 indications 219 trials
Insomnia (178 trials)
Narcolepsy (41 trials)
Endocrine
5 indications 166 trials
Acromegaly (49 trials)
Growth Hormone Deficiency (41 trials)
Adrenal Insufficiency (26 trials)
Hypothyroidism (25 trials)
Hyperthyroidism (25 trials)
How to use: Review each therapeutic area and its indications. Click "▼ aliases" to see which condition names map to each canonical indication.
Zero counts: Gray aliases haven't been seen in trial data yet (may be rare or spelling variations).
Edit taxonomy: scripts/indication-taxonomy.js